Coating of Balloon Catheters
Technology
At DOT, the balloon catheters are coated with cytostatic drugs. Application of these active substances is conducted with a defined deposition of an adjusted solution and their controlled drying. The cytostatic drugs are applied on the balloon catheter using a carrier substance and generate a so-called drug eluting balloon (DEB). During the dilatation of the balloon in the blood vessel, the cytostatic drug is released from the balloon into the vessel wall and minimises the risk of restenosis for a specified period of time.
At DOT, the balloon catheters are coated with cytostatic drugs. Application of these active substances is conducted with a defined deposition of an adjusted solution and their controlled drying. The cytostatic drugs are applied on the balloon catheter using a carrier substance and generate a so-called drug eluting balloon (DEB). During the dilatation of the balloon in the blood vessel, the cytostatic drug is released from the balloon into the vessel wall and minimises the risk of restenosis for a specified period of time.
Properties
- Homogenous, thin coating
- Drug release over a defined time period
Range of Application
- Balloon catheters for angioplasty of peripheric and coronar blood vessels
- In-stent restenosis
- Bifurcations in the coronar area as well as renal vessels, femoral arteries and lower leg arteries in the peripheral area
Advantages of the Procedure
- No foreign body in the blood vessel after after medical intervention
- Effective inhibition of new formation of cells
- Permanent local effectiveness of the released substances over a long time period
